Search Results - Andrea Ceccardi

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    <i>JAK2</i> is a critical therapeutic target in <scp>VEXAS</scp> syndrome treated with ruxolitinib

    <i>JAK2</i> is a critical therapeutic target in <scp>VEXAS</scp> syndrome treated with ruxolitinib by Andrea Ceccardi, Martina Dameri, Francesco Ravera, Nicolò Gilardi, Mario Stabile, Isabella Lombardo, Davide Ceresa, Monica Colombo, Tiziana Vigo, Benedetta Cigolini, Giulia Rivoli, Matteo Dragani, Irene Solimano, Anna Garuti, Andrea Bellodi, Alberto Ballestrero, Lorenzo Ferrando, Gabriele Zoppoli

    Published 2025
    Get full text
    Carta
    Save to List
    Saved in:

Search Tools: